HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding HCW Biologics Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 16 | 18 | +2 |
| Shares | 1.16M | 3.13M | +1.97M (+169.9%) |
| Value | $625.6K | $1.40M | +$770.2K (+123.1%) |
New holders (4)
Institutions that held HCW Biologics Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,023,664 | $902.8K | 0.02% |
| XTX Topco Ltd | 33,999 | $15.2K | 0.00% |
| Virtu Financial LLC | 15,623 | $7.00K | 0.00% |
| Renaissance Technologies LLC | 15,000 | $6.69K | 0.00% |
Sold out (2)
Institutions that held HCW Biologics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| HRT Financial LP | 46,497 | $25.0K |
| UBS Group AG | 4,831 | $2.60K |